Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Prudential PLC Sells 88,665 Shares of Pfizer Inc. $PFE
How New Multi‑Tumor Oncology Data At Pfizer (PFE) Has Changed Its Investment Story
US companies disclose huge Irish tax payments
New US corporation tax regulations could put Ireland in Trump's crosshairs
UBS Remains a Buy on Olema Pharmaceuticals (OLMA)
Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA
Pfizer (NYSE:PFE) Trading 1.4% Higher - What's Next?
Pfizer (PFE) Partners with Chai Discovery for AI-Driven Drug Development
Pfizer strikes $10.5 billion oncology deal with Chinese biotech
Natixis Advisors LLC Raises Position in Pfizer Inc. $PFE
One Capital Management LLC Cuts Position in Pfizer Inc. $PFE
Pfizer patents new PI3Kα mutant inhibitors | BioWorld
Pfizer (PFE) Valuation Check After Recent Share Price Pressure And Rebuilding Momentum
Cigarette smoking, e-cigarette use, and hypertension: a population-based cross-sectional study
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
Top 5 High-Yield Dividend Stocks for Income Investors in 2026
Pfizer vs Merck: Chasing High Yield vs Higher Returns
Bank of New York Mellon Corp Raises Stake in Pfizer Inc. $PFE
Celcuity (CELC) Shares Plunge Over 20% Following Phase 3 Trial Data
Is Pfizer Inc. (PFE) Expanding Its Cancer Pipeline Through a Landmark Innovent Partnership?
Why Pfizer's Current Price May Be Too Cheap to Ignore
Pfizer CEO Albert Bourla on the company's obesity drug pipeline
Pfizer CEO Albert Bourla on the company's oncology focus
Pfizer's ASCO 2026 Cancer Results Test Oncology Focus And Valuation Story
Pfizer Unveils Innovative Cancer Treatment Elranatamab in India, ETPharma
Work or vacation? Why global health giants are flocking to Hainan - Chinadaily.com.cn
Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort
Pfizer (NYSE:PFE) Stock Price Down 2.1% - Here's Why
Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax
Company Website: https://www.pfizer.com NEW YORK -- (Busin
Pfizer Oncology Deal And Lung Cancer Data Reshape Valuation Debate
Centene Corporation (CNC) and Pfizer (PFE) Stand Out in Valuatio
3 Cash-Producing Stocks Worth Your Attention
Pfizer Inc. $PFE Shares Acquired by Nomura Asset Management Co. Ltd.
Nomura Asset Management Co. Ltd. Has $52.42 Million Position in Pfizer Inc. $PFE - Daily Political
Assessing Celcuity (CELC) Valuation As Investor Optimism And Conflicting Fair Value Views Intensify
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Innovent Biologics and Pfizer ink $10.5 B deal to develop innovative oncology medicines
Evaluating the Clinical and Humanistic Impact of a Self-Care and Minor Ailment Service (MAS)
What To Buy If Not AI? Top Goldman Trader Finds 'Scarcity' Elsewhere
Is Pfizer Stock a "Value Trap" or a Generational Opportunity? - AOL
Pfizer (PFE) Reports Promising Results from Breakwater Trial
Cohort 3 analysis from the Phase 3 BREAKWATER study showed a
Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri
11 Most Undervalued Pharma Stocks to Invest In
Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi
How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers - Yahoo News Canada
Savant Capital LLC Has $4.02 Million Holdings in Pfizer Inc. $PFE
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?
Eurizon Capital SGR S.p.A. Acquires New Stake in Pfizer Inc. $PFE
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Business Wire Releases - Barchart.com
Why Wall Street Is Dead Wrong About This Popular Stock
Pfizer Inc. $PFE Shares Sold by Koss Olinger Consulting LLC
Norges Bank Purchases New Position in Pfizer Inc. $PFE
Fideuram Asset Management Ireland dac Purchases New Stake in Pfizer Inc. $PFE - Stock Observer
Pfizer's US$10.5b Oncology Deal With Innovent And What It Means For Valuation
Pfizer's $10.5 Billion Oncology Bet Sends Innovent Shares Surging
EMA Recommends COVID-19 Vaccines Targeting XFG Variant for 2026/2027
Pfizer (PFE) Reveals Promising Seven-Year Findings from CROWN Trial
Pfizer and I-Mab Forge $10.5 Billion Cancer Drug Development Partnership
Pfizer Expands Oncology Pipeline in $10.5B Innovent Deal
Pfizer (NYSE:PFE) Trading Up 1.5% - Here's Why - Daily Political
Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer | Morningstar
Pfizer Inc. $PFE Stake Increased by National Pension Service
Moors & Cabot Inc. Lowers Holdings in Pfizer Inc. $PFE
Fidelis Capital Partners LLC Has $1.55 Million Stock Holdings in Pfizer Inc. $PFE - Zolmax
Pfizer Enters Deal With Innovent Biologics To Co-Develop Oncology Medicines
Moors & Cabot Inc. Has $7.03 Million Stock Position in Pfizer Inc. $PFE - Stock Observer
Pfizer Inc. $PFE Shares Bought by National Pension Service - Stock Observer
Pfizer Inc. $PFE Shares Acquired by Ilmarinen Mutual Pension Insurance Co - Stock Observer
Innovent Biologics Surges After Signing Up to $10.5 Billion Deal With Pfizer | Morningstar
China's Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
Innovent Biologics, Pfizer strike $10.5b partnership deal amid China biotech boom
Innovent, Pfizer partner on 12 early-stage cancer programs | BioWorld
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal | BioWorld
Innovent shares rise 10% after pact with Pfizer of up to $10.5 billion
Pfizer inks up to $10.5 billion deal with China's Innovent Biologics
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results
Pfizer, Innovent Sign Licensing Deal to Develop 12 Cancer Drugs | Morningstar
Should Pfizer's (PFE) New 25‑Valent Vaccine Data and Oncology Alliance Require Action From Investors?
Pfizer enters into global strategic collaboration with Innovent Biologics
Wall Street Rallies Amid U.S.-Iran Peace Deal Speculation
Valneva to Participate at U.S. and European Investor Conferences in June
Insiders Aren't Buying Pfizer Stock at $26 and That's Actually a Good Thing - 24/7 Wall St.
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight
Geode Capital Management LLC Increases Stock Holdings in Pfizer Inc. $PFE - Daily Political
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial
BNT162b2 LP.8.1 early vaccine effectiveness against COVID-19 emergency department, urgent care, and outpatient visits
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders
Viking Therapeutics Buyout Buzz Meets VK2735 Obesity Drug Valuation Gap
Pfizer (NYSE:PFE) Shares Up 1.5% - Should You Buy? - Stock Observer
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference | Morningstar
Wealth Advisors of Tampa Bay LLC Lowers Holdings in Pfizer Inc. $PFE - Zolmax
PFIZER News
US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes
Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy
US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path
Latest news
Show moreMarket Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer
US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators
Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation
US May Jobs Report Exceeds Expectations, Bolstering Economic Resilience and Shifting Fed Rate Outlook
